Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05304377
Title A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia (CML)
Acronym CML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Enliven Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | AUS


No variant requirements are available.